Company: IMNN
Filing Date: 2025-05-19
Form Type: S-1/A
Source: 0001641172-25-011388
Chunk: 64

Company: Imunon, Inc.
Filing Date: 2025-05-19
Form: S-1/A
Chunk 64
---
 the Existing Warrant Holders in connection with the Warrant Exchange; and (c) there were no commissions or other remuneration paid by the Company in connection with the Warrant Exchange.

Item 16. Exhibits and Financial Statement Schedules.

(a) The exhibits set forth below have been or are being filed herewith and are numbered in accordance with Item 601 of Regulation S-K.

| II-2 |

(b) Financial statement schedules have been omitted, as the information required to be set forth therein is included in the consolidated financial statements or notes thereto incorporated by reference into the prospectus forming part of this registration statement.

| EXHIBIT 
 NO.     |     | DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 1.1

#    |     | Form of Placement Agency Agreement.                                                                                                                                                                                                                                                                                                                                                                                                              |
| 2.1*    |     | Asset Purchase Agreement dated as of June 6, 2014, by and between Imunon, Inc. and EGEN, Inc., incorporated herein by reference to Exhibit 2.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2014 (SEC File No. 001-15911).                                                                                                                                                                                 |
| 2.2     |     | Amendment to Asset Purchase Agreement between Celsion Corporation and EGWU, Inc., dated March 28, 2019 incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on April 1, 2019 (SEC File No. 001-15911).                                                                                                                                                                                        |
| 3.1     |     | Amended and Restated Certificate of Incorporation of Imunon, dated March 24, 2023, incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company filed on March 24, 2023 (SEC File No. 001-15911).                                                                                                                                                                                                            |
| 3.2     |     | Amended and Restated Bylaws of the Company, effective on March 15, 2024, incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company, filed on March 18, 2024 (SEC File No. 001-15911).                                                                                                                                                                                                                            |
| 4.1     |     | Form of Representative’s Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4